Therapy-related myelodysplastic syndrome rapidly evolving to acute myeloid leukemia following CAR-T cell therapy in a patient with refractory diffuse large B-cell lymphoma: a case report - Quiz - MDSpire

Therapy-related myelodysplastic syndrome rapidly evolving to acute myeloid leukemia following CAR-T cell therapy in a patient with refractory diffuse large B-cell lymphoma: a case report

  • By

  • Longmei Chen

  • Wanchao Liu

  • July 14, 2026

Share

Original Source(s)

Therapy-related myelodysplastic syndrome rapidly evolving to acute myeloid leukemia following CAR-T cell therapy in a patient with refractory diffuse large B-cell lymphoma: a case report

  • by Longmei Chen, Wanchao Liu

  • July 14, 2026

Related Content

What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis

T cell-mediated immune function in gastric cancer: a bibliometric overview of the last 20 years (2006-2025)

Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma